BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 22525471)

  • 61. Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
    Zhang L; Sun JH; Hou ZH; Zhong BY; Yang MJ; Zhou GH; Wang WS; Huang P; Zhang S; Li Z; Zhu XL; Yan ZP; Ni CF
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):63-72. PubMed ID: 32965582
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis: prognostic factors in a single-center study of 188 patients.
    Liu L; Zhang C; Zhao Y; Qi X; Chen H; Bai W; He C; Guo W; Yin Z; Fan D; Han G
    Biomed Res Int; 2014; 2014():194278. PubMed ID: 24800212
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus.
    Peng SY; Wang XA; Huang CY; Li JT; Hong DF; Wang YF; Xu B
    World J Gastroenterol; 2018 Oct; 24(40):4527-4535. PubMed ID: 30386102
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.
    Hata M; Tokuuye K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Ohara K; Matsuzaki Y; Tanaka N; Akine Y
    Cancer; 2005 Aug; 104(4):794-801. PubMed ID: 15981284
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.
    Huang M; Lin Q; Wang H; Chen J; Bai M; Wang L; Zhu K; Jiang Z; Guan S; Li Z; Qian J; Li M; Pang P; Shan H
    Eur Radiol; 2016 Oct; 26(10):3428-36. PubMed ID: 26792430
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
    Zhang Y; Miao H; Xie W; Jiang S; Song Z; Huang G; Fan W; Wang Y; Li J; Chen Y
    Eur Radiol; 2021 Jan; 31(1):232-243. PubMed ID: 32728770
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB; Wang JH; Yan ZP; Qian S; Liu R
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Comparison of clinical characteristics of non-B non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma and prognosis in Uighur patients].
    Zhang R; Zhou S; Xiao L; Zhang H; Tulahong A; Zhang Y; Wen H; Bao Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):540-4. PubMed ID: 26463333
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
    J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma.
    Takano M; Kokudo T; Miyazaki Y; Kageyama Y; Takahashi A; Amikura K; Sakamoto H
    World J Gastroenterol; 2016 Nov; 22(42):9445-9450. PubMed ID: 27895433
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein.
    Luo J; Yan Z; Liu Q; Qu X; Wang J
    J Vasc Interv Radiol; 2011 Apr; 22(4):479-89. PubMed ID: 21463757
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Efficacy of postoperative chemotherapy combined with immunotherapy for hepatocellular carcinoma with major portal vein tumor thrombus].
    Hu WJ; Liang LJ; Zhou Q; Peng BG; Yin XY; Li DM
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1325-7. PubMed ID: 18241566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transarterial chemoembolization in patients with hepatocellular carcinoma beyond Barcelona-Clinic Liver Cancer- B and portal vein tumor thrombosis: Experience from a tertiary care center.
    Anand S; Pottakkat B; Raja K; Chandrasekar S; Satheesh S
    Indian J Cancer; 2022; 59(3):325-329. PubMed ID: 33753610
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.
    Chen XP; Qiu FZ; Wu ZD; Zhang ZW; Huang ZY; Chen YF; Zhang BX; He SQ; Zhang WG
    Ann Surg Oncol; 2006 Jul; 13(7):940-6. PubMed ID: 16788755
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein.
    Fan J; Wu ZQ; Tang ZY; Zhou J; Qiu SJ; Ma ZC; Zhou XD; Ye SL
    World J Gastroenterol; 2001 Feb; 7(1):28-32. PubMed ID: 11819728
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification.
    Niu ZJ; Ma YL; Kang P; Ou SQ; Meng ZB; Li ZK; Qi F; Zhao C
    Med Oncol; 2012 Dec; 29(4):2992-7. PubMed ID: 22200992
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endovascular implantation of
    Sun H; Zhang M; Liu R; Liu Y; Hou Y; Wu C
    Future Oncol; 2018 May; 14(12):1165-1176. PubMed ID: 29334777
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification.
    Xu JF; Liu XY; Wang S; Wen HX
    World J Surg Oncol; 2015 Feb; 13():86. PubMed ID: 25889711
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
    Cheng YQ; Wang K; Zhang XP; Wei XB; Jiang YB; Hu YR; Mao FF; Guo WX; Shi J; Cheng SQ
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1214-1221. PubMed ID: 30402968
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.